Yeah, I thought it could have been Celgene myself. Celgene also had a competition on the IBD lines, thinking if they include IPIX on the next one (possibly during a US wide phase III) maybe they'll see how IPIX trumps the competition.
Anyway, if it wasn't Celgene that suggested to the Crohn's and Colitis Foundation to invite IPIX I'm thinking someone's looking at IPIX very closely. We get some private funding going on, look out blue skies.